Fagron Stock Price, News & Analysis (OTCMKTS:ARSUF) $17.29 0.00 (0.00%) (As of 11/29/2023 ET) Add Compare Share Share Today's Range$17.29▼$17.2950-Day Range$17.29▼$17.8852-Week Range$16.15▼$18.75VolumeN/AAverage Volume8,850 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield3.12%Price TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest About Fagron Stock (OTCMKTS:ARSUF)Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.Read More ARSUF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ARSUF Stock News HeadlinesOctober 13, 2022 | finance.yahoo.comFagron delivers topline growth of 21.5% to €173 millionSeptember 27, 2022 | finance.yahoo.comFagron commits to set science-based emission reduction targetsNovember 30, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!September 8, 2022 | reuters.comFAGRO.BR - Fagron NV | Stock Price & Latest News | ReutersSeptember 4, 2022 | yahoo.comDisclosure of received notification of Kabouter Management LLCAugust 8, 2022 | seekingalpha.comFagron NV (ARSUF) CEO Rafael Padilla on Q2 2022 Results - Earnings Call TranscriptAugust 4, 2022 | finance.yahoo.comFagron delivers strong topline growth of 18.8% and an increase in REBITDA of 13.1% for the first half of 2022June 13, 2022 | finance.yahoo.comFagron increases share capital through exercise subscription rightsNovember 30, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comMay 9, 2022 | ca.finance.yahoo.comFagron shareholders approve all voting items AGM and EGMApril 14, 2022 | uk.finance.yahoo.comFagron reports 16% increase in revenue to € 156.4 millionApril 8, 2022 | nz.finance.yahoo.comFagron publishes agenda 2022 annual general meeting and extraordinary general meetingMarch 15, 2022 | msn.comFagron expands Wichita facility, creating 150 new jobsMarch 15, 2022 | finance.yahoo.comFagron to present medium-term strategic objectives at its Capital Markets DayMarch 7, 2022 | sg.finance.yahoo.comFull year ‘21 results Fagron in line with expectationsFebruary 2, 2022 | finance.yahoo.comFagron strengthens position in US with acquisition of Letco and divestment of non-core activitiesSee More Headlines Receive ARSUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fagron and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ARSUF CUSIPN/A CIKN/A Webwww.fagron.com Phone32.8.001.28.80FaxN/AEmployees3,035Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Rafael Padilla (Age 45)CEO & Executive Director Comp: $712.8kMs. Karin de Jong (Age 44)CFO & Executive Director Comp: $1.1MMs. Vera Bakker (Age 51)Chief Operating Officer Comp: $8.22kKaren BergGlobal Investor Relations ManagerMr. Johan VerlindenHead of Legal, Mergers & AcquisitionsKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors ARSUF Stock Analysis - Frequently Asked Questions How have ARSUF shares performed in 2023? Fagron's stock was trading at $13.50 at the beginning of the year. Since then, ARSUF shares have increased by 28.1% and is now trading at $17.2877. View the best growth stocks for 2023 here. Are investors shorting Fagron? Fagron saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 16,100 shares, an increase of 7.3% from the October 15th total of 15,000 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 161.0 days. View Fagron's Short Interest. Is Fagron a good dividend stock? Fagron (OTCMKTS:ARSUF) pays an annual dividend of $0.54 per share and currently has a dividend yield of 1.72%. How do I buy shares of Fagron? Shares of ARSUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:ARSUF) was last updated on 11/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fagron NV Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.